Comparative Effectiveness of Glucose-Lowering Agents on Kidney Outcomes in Adults with Type 2 Diabetes at Moderate Cardiovascular Risk

被引：0
|
作者：
Neumiller, Joshua J.
Herrin, Jeph
Swarna, Kavya
Polley, Eric
Galindo, Rodolfo J.
Umpierrez, Guillermo
Deng, Yihong
Mickelson, Mindy
McCoy, Rozalina G.
机构：
来源：
DIABETES | 2024年 / 73卷
关键词：
D O I：
10.2337/db24-413-P
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
413-P
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk
    Rozalina G. McCoy
    Jeph Herrin
    Kavya Sindhu Swarna
    Yihong Deng
    David M. Kent
    Joseph S. Ross
    Guillermo E. Umpierrez
    Rodolfo J. Galindo
    William H. Crown
    Bijan J. Borah
    Victor M. Montori
    Juan P. Brito
    Joshua J. Neumiller
    Mindy M. Mickelson
    Eric C. Polley
    [J]. Nature Cardiovascular Research, 2024, 3 : 431 - 440
  • [2] Effectiveness of glucose-lowering medications on cardiovascular outcomes in patients with type 2 diabetes at moderate cardiovascular risk
    Mccoy, Rozalina G.
    Herrin, Jeph
    Swarna, Kavya Sindhu
    Deng, Yihong
    Kent, David M.
    Ross, Joseph S.
    Umpierrez, Guillermo E.
    Galindo, Rodolfo J.
    Crown, William H.
    Borah, Bijan J.
    Montori, Victor M.
    Brito, Juan P.
    Neumiller, Joshua J.
    Mickelson, Mindy M.
    Polley, Eric C.
    [J]. NATURE CARDIOVASCULAR RESEARCH, 2024, 3 (04): : 431 - 440
  • [3] Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes
    Kabadi, Udaya M.
    [J]. ANNALS OF INTERNAL MEDICINE, 2021, 174 (01) : 140 - 140
  • [4] Comparative Effectiveness of Glucose-Lowering Drugs for Type 2 Diabetes RESPONSE
    Tsapas, Apostolos
    Karagiannis, Thomas
    Avgerinos, Ioannis
    Matthews, David R.
    Bekiari, Eleni
    [J]. ANNALS OF INTERNAL MEDICINE, 2021, 174 (01) : 141 - 141
  • [5] Initial glucose-lowering therapy and cardiovascular outcomes in type 2 diabetes
    Misnikova, I. V.
    Dreval, A. V.
    Kovaleva, Y. A.
    [J]. DIABETOLOGIA, 2012, 55 : S326 - S326
  • [6] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Kalyani, Rita R.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (13): : 1248 - 1260
  • [7] Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
    Inzucchi, Silvio E.
    Peixoto, Aldo J.
    Testani, Jeffrey M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07): : 669 - 670
  • [8] Effects of glucose-lowering drugs on cardiovascular outcomes in patients with type 2 diabetes
    Tomlinson, Brian
    Hu, Miao
    Zhang, Yuzhen
    Chan, Paul
    Liu, Zhong-Min
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (11) : 1267 - 1271
  • [9] Cardiovascular Outcomes Trials of Glucose-Lowering Drugs or Strategies in Type 2 Diabetes
    Gerstein, Hertzel C.
    Shah, Reema
    [J]. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (01) : 97 - +
  • [10] Impact of Glucose-Lowering Medications on Cardiovascular and Metabolic Risk in Type 2 Diabetes
    Patti, Angelo Maria
    Rizvi, Ali A.
    Giglio, Rosaria Vincenza
    Stoian, Anca Pantea
    Ligi, Daniela
    Mannello, Ferdinando
    [J]. JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
12345